Document is current
Any future updates will be listed below
-
Authors
Saura, Ouriel
Rouzé, Anahita
Martin-Loeches, Ignacio
Povoa, Pedro
Kreitmann, Louis
Torres, Antoni
Metzelard, Matthieu
Du Cheyron, Damien
Lambiotte, Fabien
Tamion, Fabienne
Labruyere, Marie
Boulle Geronimi, Claire
Luyt, Charles-Edouard
Nyunga, Martine
Pouly, Olivier
Thille, Arnaud W.
Megarbane, Bruno
Saade, Anastasia
Magira, Eleni
Llitjos, Jean-François
Ioannidou, Iliana
Pierre, Alexandre
Reignier, Jean
Garot, Denis
Baudel, Jean-Luc
Voiriot, Guillaume
Plantefeve, Gaëtan
Morawiec, Elise
Asfar, Pierre
Boyer, Alexandre
Mekontso-Dessap, Armand
Bardaka, Fotini
Diaz, Emili
Vinsonneau, Christophe
Floch, Pierre-Edouard
Weiss, Nicolas
Ceccato, Adrian
Artigas, Antonio
Nora, David
Duhamel, Alain
Labreuche, Julien
Nseir, Saad
,
Bouchereau, Mathilde
Boyd, Sean
Coelho, Luis
Maizel, Julien
Cuchet, Pierre
Zarrougui, Wafa
Boyer, Déborah
Quenot, Jean-Pierre
Imouloudene, Mehdi
Pineton de Chambrun, Marc
Van der Linden, Thierry
Arrive, François
Voicu, Sebastian
Azoulay, Elie
Moglia, Edgard
Pene, Frédéric
Cilloniz, Catia
Thevenin, Didier
Larrat, Charlotte
Argaud, Laurent
Guidet, Bertrand
Contou, Damien
Beurton, Alexandra
Meguerditchian, David
Razazi, Keyvan
Tsolaki, Vassiliki
Marzouk, Mehdi
Brunin, Guillaume
Marois, Clémence
Morales, Luis
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (20/COV/0038)
Agence Nationale de la Recherche (coVAPid Project)
- License Information
-
More Information
Article History
Received: 13 July 2022
Accepted: 12 September 2022
First Online: 27 September 2022
Declarations
:
: The Ethics Committee and Institutional Review Boards approved the study protocol (Comité de Protection des Personnes Ouest VI; approved by April 14, 2020; registration number RIPH:20.04.09.60039) as minimal-risk research using data collected for routine clinical practice and waived the requirement for informed consent.
: AR received personal fees from Maat Pharma, and IML received personal fees from MSD and Gilead. AA received personal fees from Lilly Foundation and grants from Grifols and Fisher & Paykel. CEL received personal fees from Bayer, Merck, Aerogen, bioMérieux, ThermoFisher Brahms and Carmat. SN received personal fees from MSD, Bio Rad, bioMérieux, Gilead, Fisher & Paykel and Pfizer. All other authors declare no competing interests.
: Not applicable.
